Trials / Terminated
TerminatedNCT01357174
ROTATEQ™ Post-Marketing Surveillance in the Philippines
Protocol for ROTATEQ™ Post-Marketing Surveillance
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 915 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 6 Weeks – 12 Weeks
- Healthy volunteers
- Accepted
Summary
This study will collect demographic and safety information on the use of ROTATEQ™ in the Philippines.
Conditions
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2011-05-20
- Last updated
- 2015-10-30
Source: ClinicalTrials.gov record NCT01357174. Inclusion in this directory is not an endorsement.